vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
14.03
-0.46 (-3.17%)
Aug 13, 2025, 4:00 PM - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $100.53 million as of August 14, 2025. Its market cap has increased by 57.57% in one year.
Market Cap
100.53M
Enterprise Value
74.68M
1-Year Change
57.57%
Ranking
Category
Stock Price
$14.03
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $100.53M, a decrease of -71.86%. That is a compound annual growth rate of -11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 46.30M | 5.23% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |